Evidence map›Paper›PMID 34068824›Full record

Trial reportNutrients2021

Alcohol Consumption Is Associated with Poor Prognosis in Obese Patients with COVID-19: A Mendelian Randomization Study Using UK Biobank.

Xiude Fan, Zhengwen Liu, Kyle L Poulsen, Xiaoqin Wu, Tatsunori Miyata, Srinivasan Dasarathy, Daniel M Rotroff, Laura E Nagy

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Editorial: Obesity, metabolic phenotypes and COVID-19.Metabolism: clinical and experimental · 2022
    Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Xiude FanDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH 44195, USA.ORCID 0000-0001-7413-080X
Zhengwen LiuDepartment of Infectious Diseases, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710049, China.ORCID 0000-0002-3965-4947
Kyle L PoulsenDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH 44195, USA.
Xiaoqin WuDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH 44195, USA.
Tatsunori MiyataDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH 44195, USA.
Srinivasan DasarathyDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH 44195, USA.ORCID 0000-0003-1774-0104
Daniel M RotroffDepartment of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH 44195, USA.
Laura E NagyDepartment of Inflammation and Immunity, Cleveland Clinic, Cleveland, OH 44195, USA.
Cleveland Clinic · USFirst Affiliated Hospital of Xi'an Jiaotong University · CN

Funding

Medical Research Council MC_PC_17228Medical Research Council MC_QA137853NIH HHS 3R01AA027456-02S1, P50AA024333, U01AA021890 and U01AA026938NIH HHS KL2TR002547; K99AA026648NIH HHS R21 AR 071046; RO1 GM119174; RO1 DK113196; RO1 AA028190; P50 AA024333; UO1 AA026976; AA026976-03S1; R56HL141744; UO1 DK061732
6 · The paper itself

Abstract

backgroundAcute and chronic alcohol abuse has adverse impacts on both the innate and adaptive immune response, which may result in reduced resistance to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and promote the progression of coronavirus disease 2019 (COVID-19). However, there are no large population-based data evaluating potential causal associations between alcohol consumption and COVID-19.

methodsWe conducted a Mendelian randomization study using data from UK Biobank to explore the association between alcohol consumption and risk of SARS-CoV-2 infection and serious clinical outcomes in patients with COVID-19. A total of 12,937 participants aged 50-83 who tested for SARS-CoV-2 between 16 March to 27 July 2020 (12.1% tested positive) were included in the analysis. The exposure factor was alcohol consumption. Main outcomes were SARS-CoV-2 positivity and death in COVID-19 patients. We generated allele scores using three genetic variants (rs1229984 (Alcohol Dehydrogenase 1B,

resultsOf the 12,937 participants, 4496 were never or infrequent drinkers and 8441 were frequent drinkers. Both logistic regression and Mendelian randomization analyses found no evidence that alcohol consumption was associated with risk of SARS-CoV-2 infection in participants either with or without obesity (All

conclusionsOur findings suggest that alcohol consumption has adverse effects on the progression of COVID-19 in white participants with obesity, but was not associated with susceptibility to SARS-CoV-2 infection.

Indexed as

Alcohol DrinkingBiological Specimen BanksCOVID-19ObesityPolymorphism, Single NucleotideSevere acute respiratory syndrome-related coronavirusAdaptor Proteins, Signal TransducingAgedAlcohol DehydrogenaseCation Transport ProteinsDisease-Free SurvivalFemaleHumansMaleMendelian Randomization AnalysisMiddle AgedAdaptor Proteins, Signal TransducingADH1B protein, humanAlcohol DehydrogenaseCation Transport ProteinsGCKR protein, humanSLC39A8 protein, humanalcohol consumptionCOVID-19mendelian randomizationmortalitysusceptibilityUK biobank

Identifiers

PMID34068824
PMCPMC8152000
OpenAlexW3163772385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.